https://www.zonebourse.com/cours/action/CENTESSA-PHARMACEUTICALS--123219064/actualite/Centessa-Pharmaceuticals-annonce-le-dosage-du-premier-sujet-de-l-etude-PRESent-2-enregistree-eval-44310443/?utm_source=telegram&utm_medium=social&utm_campaign=share